New projects investigate cognitive screenings for Medicare patients, “jumping genes,” and sex-based health disparities.
News
Category: Honors & Awards
Kelvin Davies Inducted as American Aging Association Fellow
USC Leonard Davis School Executive Vice Dean and USC Distinguished Professor honored for his contributions to aging science, especially his pioneering work in free radical biology.
Hanson-Thorell Family Research Scholarships Support New Investigations
The awards enable USC Leonard Davis faculty members Reginald Tucker-Seeley and Marc Vermulst to study the health impacts of financial hardship and the visualization of cellular processes.
Study.com lists USC Leonard Davis School as a top gerontology school in the nation
USC's Leonard Davis School of Gerontology has been recognized as a top gerontology school in the country.
USC Leonard Davis faculty honored for mentoring and scholarship
Kelvin Davies named Distinguished Professor; Sean Curran and Jennifer Ailshire recognized as extraordinary mentors.
Three USC Leonard Davis faculty members honored at University Club
Eileen Crimmins, Reginald Tucker-Seeley and Caleb Finch are included in a new faculty recognition display of scholarly works at the Amy King Dundon-Berchtold University Club of USC.
Kelvin Davies Named Distinguished Professor
USC Leonard Davis School Professor Kelvin Davies is one of three USC faculty members to be awarded the title of distinguished professor by USC Interim President Wanda Austin.
Navigage Foundation funds new projects
The Navigage Foundation has awarded $500,000 in grants for aging research at the USC Leonard Davis School.
Kesten Lecture spotlights research potential of widely available clinical information
Professor Vincent Mor of Brown University discusses the research potential of the Minimum Data Set clinical assessment tool.
Brendan Miller earns young investigator award from Alzheimer’s Los Angeles
Brendan Miller is a neuroscience PhD student in the Cohen Lab. Miller, who recently earned a Young Investigator Award from Alzheimer’s Los Angeles (ALZLA), spoke to us about his research studying mitochondrial mutations in Alzheimer’s disease. Q: What are you hoping to discover? A: We